Latest Biologic Stories
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Mitsubishi Gas Chemical
MediVet Biologic’s collaboration with researchers at the University of Kentucky’s College of Medicine has led to a groundbreaking novel animal biologic, K9-ACV: an Autologous Cancer Vaccine
Catalent Pharma Solutions and Sanofi are to collaborate on SMARTag antibody-drug conjugate (ADC) technology with Sanofi’s proprietary antibodies.
Exclusive Licensing Agreement for CAR T Cell, TCR, NK Cell Programs and Associated Technologies for the Development of Non-Viral Adoptive Cellular Therapies GERMANTOWN, Md., BOSTON,
LAKE FOREST, Ill., Jan.
Selexis SA announced today the first therapeutic biologic generated with the Selexis SUREtechnology Platform™ has been approved for market. Geneva, Switzerland
BEIJING, Jan. 8, 2015 /PRNewswire/ -- China Biologic Products, Inc.
Moderna venture to advance mRNA vaccines and mRNA-based passive immunity therapies CAMBRIDGE, Mass., Jan.
Today, NCPDP addressed the FDA, CDER and ODAC meeting that met to review and make a recommendation on what may be the first biosimilar to receive FDA approval in the U.S., and potentially develop
- The word or words serving to define another word or expression, as in a dictionary entry.